Table 3.
Patient Outcome and Disease Response
| Patient ID | Cohort | Age (years) | Sex | Best Response by RECIST (months on study) | Metabolic Response | 111In-CS-1008 Tumor Uptake |
|---|---|---|---|---|---|---|
| 001 | 1 | 68 | Male | PD (1.6) | PMD | No |
| 002 | 1 | 64 | Male | SD (6.9) | SMD | No |
| 004 | 3 | 50 | Male | SD (2.9) | SMD | No |
| 006 | 2 | 52 | Male | PD (1.7) | PMD | No |
| 009 | 5 | 80 | Male | PD (1.7) | PMD | No |
| 015 | 5 | 63 | Female | PD (1.5) | PMD | No |
| 019 | 3 | 63 | Male | PD (1.6) | SMD | No |
| 003 | 3 | 68 | Female | SD (3.7) | SMD | Yes |
| 005 | 2 | 59 | Female | SD (3.7) | SMD | Yes |
| 007 | 4 | 83 | Male | SD (3.7) | SMD | Yes |
| 008 | 4 | 57 | Female | SD (5.5) | SMD | Yes |
| 010 | 5 | 66 | Male | SD (3.8) | PMD | Yes |
| 011 | 2 | 65 | Female | PD (1.8) | PMD | Yes |
| 012 | 3 | 65 | Male | PD (1.8) | PMD | Yes |
| 013 | 5 | 51 | Female | PD (1.6) | PMD | Yes |
| 014 | 4 | 65 | Female | PR (6.3) | PMR | Yes |
| 016 | 3 | 74 | Female | PD (1.4) | PMD | Yes |
| 017 | 5 | 54 | Male | PD (1.7) | PMD | Yes |
| 018 | 2 | 62 | Male | SD (3.2) | SMD | Yes |
Abbreviations: ID, identification; 111In-CS-1008, indium-111 labeled to CS-1008; PD, progressive disease; PMD, progressive metabolic disease; PMR, partial metabolic response; SD, stable disease; SMD, stable metabolic disease.